Avraham Raz

Title: Avraham Raz: Innovator in Cancer Research

Introduction

Avraham Raz is a prominent inventor based in West Bloomfield, MI, known for his significant contributions to cancer research. With a total of seven patents to his name, Raz has made strides in developing innovative diagnostic and treatment methods for cancer.

Latest Patents

Among his latest patents is the invention titled "Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer." This patent provides differential antibodies that recognize both the cleaved and non-cleaved forms of matrix metalloproteinases (MMPs). These antibodies serve as surrogate diagnostic markers for the presence of active MMPs in cancer, particularly in growing breast cancers. Another notable patent is the "Method for treatment of cancer by oral administration of modified pectin." This method involves administering pH modified citrus pectin to mammals afflicted with cancer, which has been shown to inhibit the metastasis of primary tumors.

Career Highlights

Throughout his career, Avraham Raz has worked with esteemed institutions such as the Barbara Ann Karmanos Cancer Institute and Wayne State University. His work has focused on advancing the understanding and treatment of cancer, contributing to both academic research and practical applications in the medical field.

Collaborations

Raz has collaborated with notable colleagues, including Ivan R Nabi and Hideomi Watanabe, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Avraham Raz's innovative work in cancer research exemplifies the vital role of inventors in advancing medical science. His patents and collaborations continue to pave the way for new diagnostic and treatment options in the fight against cancer.